The Fast Healthcare Interoperability Resources (FHIR) standard was introduced by HL7 in 2014 as a significant replacement for the HL7 V2 and V3 standards. An open standard called FHIR, which was initially drafted in 2011 makes it easier than ever for legacy systems and new apps to exchange data. FHIR was created to not only increase communication efficiency and interoperability compared to earlier standards but also to facilitate implementation by giving clear specifications and allowing
Read More
Partners
CVS Health Acquires Oak Street Health for $10.6B in Cash – M&A
What You Should Know:
- CVS Health acquires Oak Street Health in an all-cash deal of $39 per share in cash, representing an enterprise value of approximately $10.6 billion. Bringing CVS Health and Oak Street Health together can significantly benefit patients’ long-term health by reducing care costs and improving outcomes – particularly for those in underserved communities.
- Oak Street Health CEO Mike Pykosz will continue to lead Oak Street Health, which will become part of CVS
Read More
Faro Health Secures $20M to Streamline Smart Clinical Trials
What You Should Know:
- Faro Health, a cloud-computing company that is developing digital infrastructure for smart clinical trials raises $20M in Series A funding led by General Catalyst to help scale the digital transformation of clinical trials––essentially making it easier and quicker for drug developers to greatly reduce the cost and time of trials.
- The round also included participation from previous investors Section 32, Polaris Partners, Zetta Ventures, and Northpond Ventures.
Read More
Memora Health & Virtua Health Partner to Streamline Patient Experience
What You Should Know:
- Memora Health, an intelligent platform for virtual care delivery and complex care management partners with Virtua Health, the largest health system in South Jersey, to streamline care delivery and improve the patient experience.
- The partnership will leverage Memora’s clinical intelligence platform across specialties to automate clinicians’ routine care tasks and streamline care management operations with the goal of removing unnecessary barriers and making it
Read More
Blue Shield of California, Virta Health Partners to Reverse Type 2 Diabetes in California
What You Should Know:
- Blue Shield of California has expanded its partnership with Virta Health to help reverse the human and financial impact of type 2 diabetes in the state.
- The partnership marks Blue Shield as the first health plan in California to implement a digital diabetes reversal solution across multiple lines of business.
Blue Shield is first health plan in California to implement digital diabetes reversal solution across multiple lines of business.
As part of Blue
Read More
Simple HealthKit Raises $8M to Transform Health Diagnostics and Follow-Up Care
What You Should Know:
- Simple HealthKit raises $8M in Series A funding led by Initialized Capital to address health inequity with the first human-centric, end-to-end healthcare platform that builds and delivers diagnostics, treatment and follow-up care for all
- The Series A round also included participation from seed investors Kleiner Perkins, Kapor Capital and Quest Venture Partners, bringing Simple HealthKit’s total funding to date to $12M.
End-to-End Diagnostics and Digital Health
Read More
Aluna Raises $15.3M for Lung Health Management Platform
What You Should Know:
- Aluna, the award-winning lung health management platform, recently announced it has completed a $15.3 million Series B round of financing to continue growing its solution among doctors and patients managing asthma, cystic fibrosis and COPD.
- Aluna’s AI-enabled respiratory management platform allows patients to transmit data to their doctor by blowing into their innovative spirometer daily. The patient-facing app gives patients an easy way to collect symptoms,
Read More
Biden Admin Builds on Cancer Moonshot with 13 More Initiatives
What You Should Know:
- One year ago, President Joe Biden and First Lady Jill Biden reignited the Cancer Moonshot, setting an ambitious, achievable goal: to reduce the death rate from cancer by at least 50 percent over the next 25 years, and improve the experience of people and families living with and surviving cancer, ultimately ending cancer as we know it today.
- The Cancer Moonshot has spurred tremendous action across the federal government and from the public and private
Read More
Develop, Partner, Acquire or Avoid – Where’s Investment for Digital Pathology Headed in 2023?
News of Fujifilm’s recent acquisition of software provider Inspirata’s digital pathology assets was met with much interest last month, following on from robust industry debate at Global Engage’s Digital Pathology and AI Congress: Europe a few weeks prior. Their discussions centered around the progress of the market and its inevitable future developments.
Whilst our in-depth analysis of the implications of Fujifilm’s specific deal will be released soon as a part of our Premium Insights
Read More
2023’s Biggest Pharma Cybersecurity Threats to Watch
Due to the recent growth of the pharmaceutical industry, the value of highly-sensitive data stored in pharmaceutical systems and the degree of the potential damage that cyberattacks on the industry can cause, it is safe to say that pharma could be one of the most targeted industries by cybercriminals in 2023. Ransomware, phishing attacks, business applications and third-party vendors will be some of the biggest threats to this key vertical as we approach the new year.
RansomwareThe threat of
Read More
